NCT06907797NARecruiting

Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

Dana-Farber Cancer Institute

Start Date

4/1/2025

Completion Date

6/30/2027

Summary

This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.

Detailed Description

The goal of this single-arm pilot study is to test the TRIAL web application which is designed to reduce inequity in clinical trial enrollment among participants with acute leukemia. The application aims to facilitate access to clinical trials and reduce barriers for underrepresented groups. The research study procedures include screening for eligibility and questionnaires. Participation in this research study is expected to last about 14 weeks. It is expected about 75 people will participate in this study. The National Cancer Institute (NCI) and American Society of Clinical Oncology (ASCO) are providing funding for this study.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Age 18 or older * English speaking * Ability to understand and willingness to sign written informed consent * Clinical suspicion of acute leukemia * Admitted to DFCI-affiliated inpatient unit Exclusion Criteria: * Cognitive impairment rendering the individual unable to participate in beta testing * This will be assessed by focused chart review and consultation with the patients' inpatient care team. * The following populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers \<18 years old), prisoners. * Inability to participate in in-person application testing. * Patients who participated in alpha-testing through protocol 23-404 (Appendix A)

Interventions

BEHAVIORAL

TRIAL Web-Based Application

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Acute LeukemiaLeukemia

Locations

Dana-Farber Cancer Institute

Boston, Massachusetts 02215

United States